RPG Life Sciences Ltd

Stage 2 · Advancing · week 21Setup 6.8 ★★ GoodEven −0.6

As of 20 Nov 2026, RPG Life Sciences is in Stage 2, the uptrend phase, now in week 21 (since 23 Jun 2026). It closed at ₹2,541, 17.7% below its 52-week high and above its 200-day average, which is rising. In Health Care, 34.7% of stocks are in Stage 2.

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. More about the company

₹2,540.9
Close, 20 Nov 2026
-2.50% on the day
₹4,202 Cr · Small cap
Market DowntrendHealth Care 34.7% in Stage 2-11.4 pts / 20dPharmaceuticals 42.4%-13.9 pts

Pro read

Pro

Our read

Uptrend, resting below its 50-day

Setup score

6.8 ★★ Good

RS rank

Edge

Even −0.6

RPGLIFE is about 5 months into its Stage 2 advance, 8% below its 50-day average and 18% under its 52-week high. A pause below the 50-day inside an uptrend is the weakest spot of the move until it closes back above the line.

Its relative strength is 73 of 99, above the middle among NSE stocks over the past year. Pharmaceuticals ranks 7 of 106 industries by the strength of its stocks, among the leaders.

Stocks with a similar setup at this point in their move ran 0.6 points behind the average stock over the next 30 sessions on average, after costs, and their typical best close within 60 sessions was 14% above entry.

The trend read holds while it stays in Stage 2. A close below ₹2,763, its 50-day average, would put it at rest; ₹2,471, 20% under its 52-week high of ₹3,089, is where a trailing stop would sit.

Setup-score rank among Stage 2 peers: #31 of 50 in Pharmaceuticals · #40 of 61 in Health Care

Is RPGLIFE early, or has it already run? Pro answers that for every NSE stock, after every close.

Loading price chart…
Stage Cycle Timeline2023-08-24 → 2026-11-20
S2 35w
S2 22w
S4 15w
S2 22w
2023-08-242026-11-20
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 35w → S3 10w → S2 22w → S3 10w → S2 4w → S3 2w → S2 3w → S4 8w → S1 3w → S2 9w → S3 7w → S2 3w → S3 7w → S4 15w → S1 7w → S2 22w current
Total tracked: 168 weeks across 16 stage runs.

RPGLIFE among Pharmaceuticals57th of 118 by relative strength

All 118 →
Stocks in Pharmaceuticals ranked by relative strength, with stage and one-month change
#StockStageRS1M
1BLISSGVSStage 2 · wk 4999+4.6%
2KPLStage 2 · wk 4499+20.5%
3FREDUNStage 2 · wk 3398+24.0%
4VENUSREMStage 3 · wk 1098−1.5%
5RUBICONStage 3 · wk 498+18.7%
6SAKARStage 2 · wk 5598+13.1%
7BAFNAPHStage 2 · wk 2398+1.9%
8INDSWFTLABStage 2 · wk 2398−7.4%
…57RPGLIFEStage 2 · wk 2173−9.2%
vs 52W High
-17.7%
₹1,744 lo₹3,089.2 hi
17.7% below 52W high, deeper pullback
How far this stock is from its 52-week high. A stock a little below its high with its Stage 2 structure intact is in a pullback, not a breakdown.
Stage Maturity
Week 21
1w13w26w
Week 21, proven structure
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
5.9%
200 DMA: ₹2,398.6 · rising
The stock is above its 200-day average, the long-term trend line. That is where a Stage 2 advance normally trades.
Rel Volume
0.20x
vs 50-day avg
Volume was well below average. In a Stage 2 advance, quiet sessions read as the stock resting, not being sold.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-9.2%
3M
-4.8%
6M
+10.5%
YTD
+9.4%
1Y
+8.9%
Sector
Health Care
↓ Peaking
Stage 2%
34.7%
20d Δ
-11.4pp
1M return
+11.5%
3M return
+3.8%
Sector Stage-2 % · last 20 days
This stock ranks #46 of 58 Stage 2 stocks in Health Care by RS. Lagging sector peers.
Industry
Pharmaceuticals
↓ Peaking
Stage 2%
42.4%
20d Δ
-13.9pp
1M return
+8.3%
3M return
+2.1%
Industry Stage-2 % · last 20 days
Ranks #38 of 48 Stage 2 stocks in this industry.

Mutual fund holdings

Held by 4 mutual funds in portfolios to October 2026: 0 active funds and 4 index funds and ETFs.

In October, no active fund changed its holding.

All 4 funds and what each did in October

Mutual funds holding RPGLIFE: the ten largest and the month’s moves →

Fund details on DiscoverMF

Scan Membership
Not in any scan now.
Last appeared 29 Oct 2026
Last appeared 23 Jun 2026
19 appearances in the last 60 days.
Recent Stage Timeline
2026-11-20S2
Wk 21 · Vol 0.20x
2026-11-19S2
Wk 21 · Vol 0.55x
2026-11-18S2
Wk 21 · Vol 0.18x
2026-11-17S2
Wk 21 · Vol 0.16x
2026-11-16S2
Wk 20 · Vol 0.28x
2026-11-13S2
Wk 20 · Vol 0.19x
2026-11-12S2
Wk 20 · Vol 0.11x
2026-11-11S2
Wk 20 · Vol 0.20x
2026-11-09S2
Wk 20 · Vol 0.28x
2026-11-06S2
Wk 19 · Vol 0.23x
2026-11-05S2
Wk 19 · Vol 0.19x
2026-11-04S2
Wk 19 · Vol 0.30x
Moving averages & range
50 DMA
₹2,763.1
200 DMA
₹2,398.6
52W High
₹3,089.2
52W Low
₹1,744
5D Low
₹2,502.5
Resistance levels (recent highs)
20d High
₹3,003.8
60d High
₹3,089.2
120d High
₹3,089.2
250d High
₹3,089.2
Next resistance
+18.2%
to 20d High
P/E (TTM)
38.1
Forward 27.1
Earnings Growth (YoY)
-23.4%
Revenue +16.5%
ROE
+15.6%
Profit margin +14.3%
Dividend Yield
0.94%
P/B 5.8

RPG Life Sciences: quick answers

What stage is RPG Life Sciences in?

As of 20 Nov 2026, RPG Life Sciences (RPGLIFE) is in Stage 2, the uptrend phase. It entered Stage 2 on 23 Jun 2026 and is in week 21. What the four stages mean

Is RPG Life Sciences in an uptrend?

Yes. RPG Life Sciences is in a Stage 2 uptrend. It trades 5.9% above its 200-day average, which is rising.

How far is RPG Life Sciences from its 52-week high?

RPG Life Sciences closed at ₹2,541 on 20 Nov 2026, 17.7% below its 52-week high of ₹3,089. Its 52-week low is ₹1,744.

How has RPG Life Sciences performed over the past year?

As of 20 Nov 2026, RPG Life Sciences is up 8.9% over the past year and up 9.4% so far in 2026.

Which sector and industry is RPG Life Sciences in?

RPG Life Sciences is in the Pharmaceuticals industry, part of the Health Care sector. 61 stocks in Health Care are in Stage 2, 34.7% of the sector. See the Stage 2 stocks in Pharmaceuticals

About this companyHealth Care· Pharmaceuticals

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology and pediatrics, cardiovascular, pediatrics, neurology, anti-dengue, dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.

Visit company website →

All analytics based on EOD data. Data as of 2026-11-20. Past data patterns are not indicative of future results. This page is a data analytics tool only.